Role of miR-27a, miR-181a and miR-20b in gastric cancer hypoxia-induced chemoresistance

Cancer Biology & Therapy
Katia DanzaStefania Tommasi

Abstract

Despite the search for new therapeutic strategies for gastric cancer (GC), there is much evidence of progression due to resistance to chemotherapy. Multidrug resistance (MDR) is the ability of cancer cells to survive after exposure to chemotherapeutic agents. The involvement of miRNAs in the development of MDR has been well described but miRNAs able to modulate the sensitivity to chemotherapy by regulating hypoxia signaling pathways have not yet been fully addressed in GC. Our aim was to analyze miR-20b, miR-27a and miR-181a expression with respect to (epirubicin/oxaliplatin/capecitabine (EOX)) chemotherapy regimen in a set of GC patients, in order to investigate whether miRNAs deregulation may influence GC MDR also via hypoxia signaling modulation. Cancer biopsy were obtained from 21 untreated HER2 negative advanced GC patients, retrospectively analyzed. All patients received a first-line chemotherapy (EOX) regimen. MirWalk database was used to identify miR-27a, miR-181a and miR-20b target genes. The expression of miRNAs and of HIPK2, HIF1A and MDR1 genes were detected by real-time PCR. HIPK2 localization was assessed by immunohistochemistry. Our data showed the down-regulation of miR-20b, miR-27a, miR-181a concomitantly to hi...Continue Reading

References

Jan 7, 2003·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Maria WartenbergHeinrich Sauer
Feb 10, 2007·The Journal of Clinical Investigation·Giovanna Maria PierantoniAlfredo Fusco
Jan 4, 2008·The New England Journal of Medicine·David CunninghamUNKNOWN Upper Gastrointestinal Clinical Studies Group of the National Cancer Research Institute of the United Kingdom
Jul 23, 2008·Molecular Cancer Therapeutics·Olga KovalchukIgor P Pogribny
Dec 23, 2008·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·E A EisenhauerJ Verweij
Jul 28, 2009·International Journal of Cancer. Journal International Du Cancer·Tongsen ZhengLianxin Liu
Sep 18, 2009·Journal of Cancer Research and Clinical Oncology·Lei HuangDing Ma
Mar 5, 2010·The New England Journal of Medicine·David CunninghamSue Ashley
Nov 13, 2010·Journal of Cellular and Molecular Medicine·Dan-Dan FengYue-Qin Chen
Jan 29, 2011·Cell Death and Differentiation·Y HuangE Ratovitski
May 17, 2011·Journal of Experimental & Clinical Cancer Research : CR·Xiaohong ZhaoJianguo Hu
May 25, 2011·Journal of Biomedical Informatics·Harsh DweepNorbert Gretz
Jun 6, 2012·DNA and Cell Biology·Julia D Toscano-Garibay, Guillermo Aquino-Jarquin
Aug 31, 2012·Anti-cancer Agents in Medicinal Chemistry·Albert BreierZdenka Sulova
Sep 25, 2012·Journal of Molecular Cell Biology·Vera V SaulM Lienhard Schmitz
Apr 23, 2013·Biochemical and Biophysical Research Communications·Fang WangDaiming Fan
May 29, 2013·Free Radical Biology & Medicine·Shriram NallamshettyJoseph Loscalzo
Nov 8, 2013·Cell Cycle·Tilman Polonio-VallonThomas G Hofmann
Mar 22, 2014·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Ana FerroNuno Lunet
May 3, 2014·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Andreas GiselNicola Antonio Colabufo

❮ Previous
Next ❯

Citations

Mar 5, 2019·Artificial Cells, Nanomedicine, and Biotechnology·Liang ZhangHai-Rong Yao
Dec 10, 2017·Oncotarget·Nicola SilvestrisStefania Tommasi
Mar 22, 2019·International Journal of Oncology·Chao ChenJingjing Liu
Jun 5, 2020·Cellular Oncology (Dordrecht)·Arash PoursheikhaniSadegh Babashah
Dec 5, 2019·World Journal of Gastrointestinal Oncology·Ya-Jun LuoJiang-Wei Xiao
Aug 11, 2020·Molecular Biology Reports·Shirin AzarbarzinBehzad Baradaran
Jul 8, 2020·International Journal of Molecular Sciences·Iwona Bednarz-MisaMałgorzata Krzystek-Korpacka
Oct 22, 2020·Cellular and Molecular Life Sciences : CMLS·Paresh Kumar Purohit, Neeru Saini
Oct 31, 2020·Expert Review of Gastroenterology & Hepatology·Kuo YangSamiullah Khan
Dec 29, 2020·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Ce XingFeng Bai
Oct 5, 2019·Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy·Yehuda G AssarafM Helena Vasconcelos
Nov 11, 2019·Molecular Aspects of Medicine·Cornelia BraicuIoana Berindan-Neagoe
Nov 3, 2020·Frontiers in Immunology·Elham SafarzadehBehzad Baradaran
Dec 19, 2020·Gastroenterology Research and Practice·Hong LinLiming Chen
Dec 10, 2020·Cancer Management and Research·Wen-Jie HuangPeng Shu
Mar 9, 2021·Frontiers in Oncology·Zhiheng ChengTiansheng Zeng
Jun 3, 2021·International Journal of Molecular Sciences·Rikako Sanuki, Tomonori Yamamura
Aug 7, 2021·Environmental Science and Pollution Research International·Ahmed ElfadadnyMohamed Elbadawy
Oct 26, 2021·Journal of Pharmaceutical Sciences·Saba HammadRania Harati
Mar 27, 2020·Current Molecular Medicine·Xi ZengYong-Ning Zhou

❮ Previous
Next ❯

Methods Mentioned

BETA
transfection
biopsy
PCR

Software Mentioned

mirWalk
GraphPad Prism

Related Concepts

Related Feeds

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.